Table 1.
Amyloid negative (n=183) |
Amyloid positive (n=61) |
Group difference
|
||
---|---|---|---|---|
t / χ | P (unadjusted) |
|||
Age (years) | 73.48 (6.23) | 75.62 (6.16) | −2.34 | 0.021* |
Education (years) | 15.62 (3.20) | 16.34 (2.81) | −1.68 | 0.097 |
Sex (Female, n (%)) | 110 (60.11%) | 37 (60.66%) | 0.01 | 0.940 |
APOE+ (n, %)^ | 33 (21.29%) | 29 (53.70%) | 20.64 | 5.541e-06*** |
MMSE (score) | 29.04 (1.08) | 28.85 (1.08) | 1.17 | 0.247 |
Memory factor score | −0.037 (0.75) | −0.035 (0.73) | −0.02 | 0.987 |
PiB - PET levels (DVR) | 1.085 (0.05) | 1.421 (0.15) | −17.72 | 2.2e-16*** |
Left hippocampal volume | 3680.64 (451.37) | 3533.08 (484.21) | 2.10 | 0.039* |
Right hippocampal volume | 3791.47 (404.59) | 3639.10 (468.65) | 2.27 | 0.025* |
Left HCB, FA | 0.354 (0.03) | 0.353 (0.03) | 0.28 | 0.784 |
Right HCB, FA | 0.348 (0.03) | 0.346 (0.04) | 0.46 | 0.648 |
Left HCB, MD$ | 0.879 (0.10) | 0.887 (0.10) | −0.53 | 0.598 |
Right HCB, MD$ | 0.890 (0.11) | 0.911 (0.13) | −1.14 | 0.256 |
Left PCC tau (SUVr)# | 1.192 (0.16) | 1.301 (0.20) | −2.91 | 0.005** |
Right PCC tau (SUVr)# | 1.242 (0.16) | 1.309 (0.19) | −1.93 | 0.059 |
Mean and standard deviations (or n and % for dichotomous variables) are provided. Two-sided Welsh t-tests were used to calculate group differences for the continuous variables and chi-square for comparing proportions across both groups. Hippocampal volumes are adjusted for intracranial volume.
Abbreviations: MMSE = Mini-Mental State Examination, PiB = Pittsburg Compound B, DVR = dynamic volume ratio, HCB = Hippocampal cingulum bundle, FA = Fractional Anisotropy, MD = Mean Diffusivity. CI = Confidence interval;
p < 0.05;
p < 0.001,
tau binding levels are from the first tau PET measurement (103 amyloid negative; 36 amyloid positive individuals),
Missing data for APOE ε4 status for amyloid negative (n=28) and amyloid positive (n=7) individuals,
MD measures were multiplied by 1000. Axial and Radial diffusivity values correlated with the MD measurements at r = 0.96 and r = 0.99 respectively.